A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools.
OBJECTIVE
The aim of this study was to assess the value of power Doppler ultrasound (PDUS) in combination with routine management in a cohort of patients with very early inflammatory arthritis (IA).


METHODS
50 patients with < or =12 weeks of inflammatory symptoms with or without signs had clinical, laboratory and imaging assessments. Diagnosis was recorded at 12 months. Assuming a 15% pre-test probability of IA, post-test probabilities for various assessments were calculated and used to develop a diagnostic algorithm.


RESULTS
All patients positive for rheumatoid factor (RF) and/or cyclic citrullinated peptide (CCP) developed persistent IA, so the added value of PDUS was assessed in the seronegative (RF and CCP negative) group. The probability of IA in a seronegative patient was 6%. The addition of clinical and radiographic features raised the probability of IA to 30% and, with certain ultrasound features, this rose to 94%.


CONCLUSIONS
In seronegative patients with early IA, combining PDUS with routine assessment can have a major impact on the certainty of diagnosis.
Freeston
J E
JE
University of Leeds, Chapel Allerton Hospital, UK.
Wakefield
R J
RJ
Conaghan
P G
PG
Hensor
E M A
EM
Stewart
S P
SP
Emery
P
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000000981:diagnostic imaging*; D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D003663:Decision Trees; D042241:Early Diagnosis; D005260:Female; D050823:Hand Joints / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000276:immunology; D011379:Prognosis; D012217:Rheumatoid Factor / Q000097:blood; D012680:Sensitivity and Specificity; D018608:Ultrasonography, Doppler / Q000379:methods; D055815:Young Adult
D001323:Autoantibodies; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D012217:Rheumatoid Factor